It has previously been reported in an in vivo ovarian cancer model that tumor infiltrating DCs have the ability to undergo endothelial-like differentiation, promoting tumor vasculogenesis, due to VEGF-A overexpression by DCs31. Here, VEGFA is linked to ovarian cancer.